| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| terbinafine hydrochloride | Tablet, uncoated | 281.25 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 27/06/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
| bicalutamide | Tablet, film coated | 50 mg | Anticipated | Available | Unexpected increase in consumer demand | 27/06/2025 |
| hydrocortisone sodium succinate | Injection, powder for | 134 mg | Resolved | Available | Unexpected increase in consumer demand | 27/06/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
| candesartan cilexetil | Tablet, uncoated | 16 mg | Current | Unavailable | Manufacturing | 27/06/2025 |
| quetiapine fumarate | Tablet, modified release | 460.52 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
| clopidogrel besilate | Tablet, film coated | 112.1 mg | Current | Unavailable | Manufacturing | 27/06/2025 |
| nicorandil | Tablet | 20 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
| neostigmine methylsulfate | Injection, solution | 2.5 mg | Resolved | Available | Manufacturing | 27/06/2025 |
| pemetrexed disodium | Injection, powder for | 1102.9 mg | Current | Unavailable | Manufacturing | 27/06/2025 |
| rifampicin | Capsule | 300 mg | Current | Unavailable | Manufacturing | 27/06/2025 |
| irbesartan | Tablet, film coated | 300 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
| flucloxacillin sodium monohydrate | Injection, powder for | 544.1 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 27/06/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
| flecainide acetate | Tablet | 50 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
| methylphenidate hydrochloride | Capsule, hard | 40 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 27/06/2025 |
| paracetamol | Tablet, modified release | 665 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 27/06/2025 |
| tirzepatide | Injection, solution | 5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
| tirzepatide | Injection, solution | 7.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
| tirzepatide | Injection, solution | 12.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
| tirzepatide | Injection, solution | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
| tirzepatide | Injection, solution | 15 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
| tirzepatide | Injection, solution | 2.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2025 |
| rifampicin | Capsule, hard | 300 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
| rifabutin | Capsule, hard | 150 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
| propofol | Injection, emulsion | 10 mg/mL | Current | Unavailable | Manufacturing | 27/06/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Anticipated | Available | Manufacturing | 27/06/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Limited Availability | Manufacturing | 27/06/2025 |
| Equine antithymocyte immunoglobulin | Injection, solution | 50 mg/mL | Anticipated | Available | Manufacturing | 26/06/2025 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Unavailable | Manufacturing | 26/06/2025 |
| dopamine hydrochloride | Injection, concentrated | 40 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 26/06/2025 |
| omeprazole magnesium | Tablet, enteric coated | 20.6 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 26/06/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 26/06/2025 |
| Follitropin alfa | Injection, solution | 150 IU | Current | Unavailable | Manufacturing | 26/06/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 26/06/2025 |
| lidocaine hydrochloride | Injection, solution | 400 mg | Discontinued | Unavailable | Manufacturing | 26/06/2025 |
| methylphenidate hydrochloride | Capsule, hard | 20 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 26/06/2025 |
| methylphenidate hydrochloride | Capsule, hard | 60 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 26/06/2025 |
| mirtazapine | Tablet, film coated | 30 mg | Anticipated | Available | Manufacturing | 26/06/2025 |
| albendazole | Tablet, chewable | 400 mg | Current | Unavailable | Manufacturing | 26/06/2025 |
| verapamil hydrochloride | Tablet, modified release | 240 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Resolved | Available | Manufacturing | 25/06/2025 |
| amiodarone hydrochloride | Injection, solution | 150 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 25/06/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Unexpected increase in consumer demand | 25/06/2025 |
| aripiprazole | Tablet, uncoated | 10 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
| indapamide hemihydrate~perindopril erbumine | Tablet | 1.25 mg~4 mg | Anticipated | Available | Manufacturing | 25/06/2025 |
| risperidone | Tablet, film coated | .5 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
| esomeprazole | Capsule, enteric | 20 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
| solifenacin succinate | Tablet | 5 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 25/06/2025 |
| busulfan | Injection, concentrated | 60 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, film coated | 10 mg~20.681 mg | Resolved | Available | Manufacturing | 25/06/2025 |
| dorzolamide hydrochloride~timolol maleate | Eye Drops, solution | 22.26 mg/mL~6.83 mg/mL | Current | Limited Availability | Manufacturing | 25/06/2025 |
| bortezomib | Injection, solution | 3.5 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
| levothyroxine sodium | Tablet, uncoated | .05 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
| levothyroxine sodium | Tablet, uncoated | .075 mg | Current | Limited Availability | Manufacturing | 25/06/2025 |
| azithromycin dihydrate | Tablet, film coated | 524 mg | Resolved | Available | Unexpected increase in consumer demand | 25/06/2025 |
| sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, film coated | 56.69 mg~500 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
| metformin hydrochloride~sitagliptin hydrochloride monohydrate | Tablet, film coated | 850 mg~56.69 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
| metformin hydrochloride~sitagliptin hydrochloride monohydrate | Tablet, film coated | 1000 mg~56.69 mg | Current | Unavailable | Manufacturing | 25/06/2025 |
| sodium amidotrizoate~amidotrizoate meglumine | Injection, solution | 40 mg/mL~260 mg/mL | Resolved | Available | Manufacturing | 25/06/2025 |
| antimony trisulfide | Injection, solution | 1.1 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 25/06/2025 |
| omeprazole | Capsule | 20 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 25/06/2025 |
| tiagabine hydrochloride monohydrate | Tablet, film coated | 5.73 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 24/06/2025 |
| tiagabine hydrochloride monohydrate | Tablet, film coated | 11.5 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 24/06/2025 |
| tiagabine hydrochloride monohydrate | Tablet, film coated | 17.2 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 24/06/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 24/06/2025 |
| midazolam | Injection, solution | 5 mg/mL | Anticipated | Available | Manufacturing | 24/06/2025 |
| risperidone | Tablet, film coated | 2 mg | Anticipated | Available | Manufacturing | 24/06/2025 |
| hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Resolved | Available | Manufacturing | 24/06/2025 |
| ropivacaine hydrochloride | Injection, solution | 150 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 24/06/2025 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Current | Limited Availability | Unexpected increase in consumer demand | 24/06/2025 |
| quetiapine fumarate | Tablet, modified release | 172.695 mg | Resolved | Available | Unexpected increase in consumer demand | 24/06/2025 |
| paclitaxel | Injection, concentrated | 300 mg | Anticipated | Available | Manufacturing | 24/06/2025 |
| rifampicin | Capsule | 150 mg | Anticipated | Available | Manufacturing | 24/06/2025 |
| armodafinil | Tablet, uncoated | 50 mg | Resolved | Available | Manufacturing | 24/06/2025 |
| metformin hydrochloride | Tablet, film coated | 500 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 24/06/2025 |
| moxonidine | Tablet, film coated | 200 microgram | Resolved | Available | Manufacturing | 24/06/2025 |
| rivaroxaban | Tablet, film coated | 2.5 mg | Resolved | Available | Unexpected increase in consumer demand | 24/06/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Resolved | Available | Unexpected increase in consumer demand | 24/06/2025 |
| Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) | Injection, powder for | 200000000 CFU | Current | Unavailable | Manufacturing | 24/06/2025 |
| estradiol hemihydrate | Drug delivery system, transdermal | 2.32 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/06/2025 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Manufacturing | 23/06/2025 |
| olanzapine | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 23/06/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Resolved | Available | Manufacturing | 23/06/2025 |
| prucalopride succinate | Tablet, film coated | 2.642 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 23/06/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Anticipated | Available | Manufacturing | 23/06/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Limited Availability | Manufacturing | 23/06/2025 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Resolved | Available | Manufacturing | 23/06/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
| candesartan cilexetil | Tablet, uncoated | 32 mg | Current | Limited Availability | Manufacturing | 23/06/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Unexpected increase in consumer demand | 23/06/2025 |
| linezolid | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Current | Unavailable | Unexpected increase in consumer demand | 23/06/2025 |
| hydromorphone hydrochloride | Injection, solution | 2 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/06/2025 |
| hydromorphone hydrochloride | Injection, solution | 10 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/06/2025 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
| fenofibrate | Tablet | 145 mg | Resolved | Available | Manufacturing | 23/06/2025 |
| mupirocin calcium | Ointment | 21.5 mg/g | Anticipated | Available | Manufacturing | 23/06/2025 |
| Semaglutide | Injection, solution | 1.34 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/06/2025 |
| Semaglutide | Injection, solution | 1.34 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 23/06/2025 |
| levothyroxine sodium | Tablet | .2 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
| isoprenaline hydrochloride | Injection, solution | 1 mg | Current | Unavailable | Manufacturing | 23/06/2025 |
| Semaglutide | Injection, solution | .68 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 23/06/2025 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 23/06/2025 |
| Measles virus~Mumps virus~Rubella virus | Injection, powder for | 1000 CCID50~5000 CCID50~1000 CCID50 | Current | Limited Availability | Unexpected increase in consumer demand | 23/06/2025 |
2025年6月30日